v3.26.3
SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Expenses by Segment In addition, research and development and selling, general and administrative expenses are significant segment expenses regularly provided to the CEO with the following categories:
Research and Development
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In thousands)
2026202520262025
Clinical research and outside services$239,525 $170,756 $683,008 $438,791 
Compensation and related121,722 146,089 371,410 388,726 
Occupancy and all other costs(1)
47,291 41,969 132,120 120,040 
Total research and development expense
$408,538 $358,814 $1,186,538 $947,557 
Selling, General and Administrative
Three Months Ended
September 30,		Nine Months Ended
September 30,
(In thousands)
2026202520262025
Compensation and related
$167,544 $188,669 $497,240 $511,339 
Consulting and professional services
118,917 88,738 344,815 236,062 
Occupancy and all other costs(1)
55,539 44,669 170,418 137,938 
Total selling, general and administrative expense
$342,000 $322,076 $1,012,473 $885,339 
(1) Occupancy and all other costs includes facilities, information technology, depreciation and certain departmental expenses